Kristell Lebozec

Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity

Élise Dalmas, Amine Toubal, Fawaz Alzaïd et al. · Nature Medicine · 2015 · 192 citations

Inflammation, Metabolic Syndrome, Obesity +15

Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab

Christine Voors‐Pette, Kristell Lebozec, Peter Dogterom et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2019 · 111 citations · Full text

Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks

Kristell Lebozec, Martine Jandrot‐Perrus, Gilles Avenard et al. · mAbs · 2017 · 89 citations · Full text

Anionic polymers for decreased toxicity and enhanced in vivo delivery of siRNA complexed with cationic liposomes

Anne Schlegel, Céline Largeau, Pascal Bigey et al. · Journal of Controlled Release · 2011 · 77 citations

Nanomedicine, Engineering, Cationic Liposomes +9

Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: A case study prior to pharmaceutical development

Kristell Lebozec, Martine Jandrot‐Perrus, Gilles Avenard et al. · New Biotechnology · 2018 · 39 citations

Recombinant Antibody Fragment, Pharmaceutical Development, Cost Assessment +8